Correlation Between Caribou Biosciences and Benitec Biopharma
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Benitec Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Benitec Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Benitec Biopharma Ltd, you can compare the effects of market volatilities on Caribou Biosciences and Benitec Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Benitec Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Benitec Biopharma.
Diversification Opportunities for Caribou Biosciences and Benitec Biopharma
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and Benitec is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Benitec Biopharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Benitec Biopharma and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Benitec Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Benitec Biopharma has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Benitec Biopharma go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Benitec Biopharma
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Benitec Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.12 times less risky than Benitec Biopharma. The stock trades about -0.02 of its potential returns per unit of risk. The Benitec Biopharma Ltd is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 919.00 in Benitec Biopharma Ltd on September 28, 2024 and sell it today you would earn a total of 281.00 from holding Benitec Biopharma Ltd or generate 30.58% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Benitec Biopharma Ltd
Performance |
Timeline |
Caribou Biosciences |
Benitec Biopharma |
Caribou Biosciences and Benitec Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Benitec Biopharma
The main advantage of trading using opposite Caribou Biosciences and Benitec Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Benitec Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Benitec Biopharma will offset losses from the drop in Benitec Biopharma's long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Benitec Biopharma vs. Fate Therapeutics | Benitec Biopharma vs. Caribou Biosciences | Benitec Biopharma vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |